Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Home
Profiles
Departments
Research output
Activities
Search by expertise, name or affiliation
Pharmaceutical management of bone catabolism: the bisphosphonates
E. J. Raubenheimer
*
, C. E.E. Noffke
, L. B. Lemmer
, T. Slavik
, W. F.P. van Heerden
,
H. D. Miniggio
*
Corresponding author for this work
Oral Biology
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmaceutical management of bone catabolism: the bisphosphonates'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bisphosphonates
100%
Pharmaceutical Management
100%
Catabolism
100%
Mechanism of Action
60%
South Africa
40%
Management Regimen
40%
Bisphosphonate Therapy
40%
Clinical Application
20%
Necrosis
20%
Clinical Complications
20%
Irritation
20%
Skeletal Disorders
20%
Osteoporosis
20%
Bowel
20%
Popular
20%
PubMed
20%
Appropriate Management
20%
Document Information
20%
Google Scholar
20%
Clinical Indications
20%
Skeletal Health
20%
Tachycardia
20%
Metastatic Disease
20%
Bone Disease
20%
Alternative Management
20%
Paget's Disease of Bone
20%
Jawbone
20%
Atypical Femur Fracture
20%
Bone Osteogenesis
20%
Catabolic
20%
Hypercalcemia
20%
Action Principle
20%
Osteogenesis Imperfecta
20%
Adverse Complications
20%
Background Conditions
20%
Medicine and Dentistry
Bisphosphonate
100%
Bone Disease
28%
Necrosis
14%
Skeleton
14%
Drug
14%
Lower Jaw
14%
Metastatic Carcinoma
14%
Contraindication
14%
Osteoporosis
14%
Tachyarrhythmia
14%
Hypercalcaemia
14%
Glucocorticoid
14%
Femur Fracture
14%
Paget Bone Disease
14%
Osteogenesis Imperfecta
14%
Pharmacology, Toxicology and Pharmaceutical Science
Bisphosphonic Acid Derivative
100%
Bone Disease
28%
Drug
14%
Necrosis
14%
Hypercalcaemia
14%
Glucocorticoid
14%
Metastasis
14%
Femur Fracture
14%
Paget Bone Disease
14%
Tachycardia
14%
Osteogenesis Imperfecta
14%